Remarkably, it has been recently reported by Gauthier and colleagues the possibility to generate tri-functional NK cell engagers (NKCEs), which can target NKp46 and CD16 on NK cells and a tumor antigen on cancer cells [210,240]. This evidence concerns the gene NCR1 and neoplasm.